JP2018524019A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524019A5 JP2018524019A5 JP2018515195A JP2018515195A JP2018524019A5 JP 2018524019 A5 JP2018524019 A5 JP 2018524019A5 JP 2018515195 A JP2018515195 A JP 2018515195A JP 2018515195 A JP2018515195 A JP 2018515195A JP 2018524019 A5 JP2018524019 A5 JP 2018524019A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- molecular weight
- polypeptide
- isolated
- high molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021158128A JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562171889P | 2015-06-05 | 2015-06-05 | |
| US62/171,889 | 2015-06-05 | ||
| US201562257607P | 2015-11-19 | 2015-11-19 | |
| US62/257,607 | 2015-11-19 | ||
| PCT/US2016/035858 WO2016197018A1 (en) | 2015-06-05 | 2016-06-03 | Endostatin fragments and variants for use in treating fibrosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021158128A Division JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018524019A JP2018524019A (ja) | 2018-08-30 |
| JP2018524019A5 true JP2018524019A5 (enExample) | 2019-07-04 |
| JP6952685B2 JP6952685B2 (ja) | 2021-10-20 |
Family
ID=56236074
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018515195A Expired - Fee Related JP6952685B2 (ja) | 2015-06-05 | 2016-06-03 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
| JP2021158128A Active JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021158128A Active JP7404320B2 (ja) | 2015-06-05 | 2021-09-28 | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10844392B2 (enExample) |
| EP (1) | EP3303383A1 (enExample) |
| JP (2) | JP6952685B2 (enExample) |
| KR (1) | KR20180033499A (enExample) |
| CN (2) | CN107849117B (enExample) |
| AU (2) | AU2016270428B2 (enExample) |
| BR (1) | BR112017026209A2 (enExample) |
| CA (1) | CA2988299C (enExample) |
| WO (1) | WO2016197018A1 (enExample) |
| ZA (1) | ZA201708223B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6952685B2 (ja) * | 2015-06-05 | 2021-10-20 | アイバイオ・インコーポレイテッドＩｂｉｏ， Ｉｎｃ． | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
| EP3850003A1 (en) * | 2018-09-14 | 2021-07-21 | The Board of Trustees of the Leland Stanford Junior University | Spd-1 variant - fc fusion proteins |
| US20210008173A1 (en) * | 2019-07-10 | 2021-01-14 | Musc Foundation For Research Development | Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury |
| EP3996694A1 (en) * | 2019-07-31 | 2022-05-18 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Peptides as inhibitors of fibrotic matrix accumulation |
| JP7493945B2 (ja) * | 2020-01-28 | 2024-06-03 | ポーラ化成工業株式会社 | 培養組織の観察方法、培養方法、評価方法及び培養器具 |
| WO2022006601A1 (en) * | 2020-07-02 | 2022-01-06 | Northwestern University | Human recombinant ace2-fc mutants that decouple anti-sars-cov-2 activity from cardiovascular effects |
| EP4251130A4 (en) * | 2020-11-30 | 2024-12-11 | Fred Hutchinson Cancer Center | Compositions and methods for selective depletion of target molecules |
| IL311163A (en) * | 2021-09-07 | 2024-04-01 | Musc Found For Res Dev | Endostatin peptides for the treatment of tumors, fibrosis and acute lung injury |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US750375A (en) | 1904-01-26 | Potato-digger | ||
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3832253A (en) | 1973-03-21 | 1974-08-27 | Baxter Laboratories Inc | Method of making an inflatable balloon catheter |
| US4667014A (en) | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US7045313B1 (en) | 1982-11-30 | 2006-05-16 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| IT1164225B (it) | 1983-05-13 | 1987-04-08 | Anic Spa | Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione |
| CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5091309A (en) | 1986-01-16 | 1992-02-25 | Washington University | Sindbis virus vectors |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5093258A (en) | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
| US5217879A (en) | 1989-01-12 | 1993-06-08 | Washington University | Infectious Sindbis virus vectors |
| US6406697B1 (en) | 1989-02-23 | 2002-06-18 | Genentech, Inc. | Hybrid immunoglobulins |
| US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| JP3039802B2 (ja) | 1989-07-06 | 2000-05-08 | ザ リージェンツ オブザ ユニバーシティ オブ カリフォルニア | 繊維芽細胞成長因子のための受容体 |
| JPH04167172A (ja) | 1990-10-31 | 1992-06-15 | Nec Corp | ベクトルプロセッサ |
| US5756671A (en) | 1994-06-02 | 1998-05-26 | Mitotix, Inc. | CDC37 cell-cycle regulatory protein, and uses related thereto |
| US6080560A (en) * | 1994-07-25 | 2000-06-27 | Monsanto Company | Method for producing antibodies in plant cells |
| US5541087A (en) * | 1994-09-14 | 1996-07-30 | Fuji Immunopharmaceuticals Corporation | Expression and export technology of proteins as immunofusins |
| US6165460A (en) | 1995-07-10 | 2000-12-26 | Therion Biologics Corporation | Generation of immune responses to prostate-specific antigen (PSA) |
| US5925351A (en) | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| DE19535939A1 (de) | 1995-09-27 | 1997-04-03 | Agfa Gevaert Ag | Fotografisches Material |
| CN1284134A (zh) | 1997-12-08 | 2001-02-14 | 贝斯以色列护理医疗中心 | 利用毕赤氏酵母表达系统生产抗生血管蛋白质∶制管张素,内抑制素或静息蛋白的方法 |
| US6218371B1 (en) | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| JP2002517186A (ja) * | 1998-06-03 | 2002-06-18 | ザ チルドレンズ メディカル センター コーポレイション | エンドスタチンタンパク質を含むタンパク質オリゴマー組成物およびその使用方法 |
| US6399075B1 (en) | 1998-07-02 | 2002-06-04 | President And Fellows Of Harvard College | Compositions and methods for treating Papillomavirus-infected cells |
| JP2003517280A (ja) | 1999-02-05 | 2003-05-27 | トーマス・ジェファーソン・ユニバーシティ | トランス相補性システムを用いての植物における生物医学用ペプチド及びタンパク質の生成 |
| AU3224700A (en) | 1999-02-08 | 2000-08-25 | Chiron Corporation | Fibroblast growth factor receptor-immunoglobulin fusion |
| US7491509B2 (en) | 2003-02-03 | 2009-02-17 | Fraunhofer Usa, Inc. | System for expression of genes in plants |
| US7692063B2 (en) * | 2002-11-12 | 2010-04-06 | Ibio, Inc. | Production of foreign nucleic acids and polypeptides in sprout systems |
| US20060024272A1 (en) * | 2004-07-29 | 2006-02-02 | Large Scale Biology Corporation | C-terminally truncated interferon |
| EP2173377B1 (en) * | 2007-06-26 | 2017-11-29 | University of Miami | Antibody-endostatin fusion protein and its variants |
| US8507441B2 (en) | 2009-10-22 | 2013-08-13 | University of Pittsburgh—Of the Commonwealth Systems of Higher Education | Use of endostatin peptides for the treatment of fibrosis |
| US20140057831A1 (en) * | 2011-07-19 | 2014-02-27 | Thrasos Innovation, Inc. | Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis |
| JP6952685B2 (ja) | 2015-06-05 | 2021-10-20 | アイバイオ・インコーポレイテッドＩｂｉｏ， Ｉｎｃ． | 線維症の治療において使用するためのエンドスタチン断片およびバリアント |
-
2016
- 2016-06-03 JP JP2018515195A patent/JP6952685B2/ja not_active Expired - Fee Related
- 2016-06-03 CN CN201680044858.5A patent/CN107849117B/zh active Active
- 2016-06-03 US US15/579,690 patent/US10844392B2/en not_active Expired - Fee Related
- 2016-06-03 EP EP16732386.4A patent/EP3303383A1/en not_active Withdrawn
- 2016-06-03 BR BR112017026209A patent/BR112017026209A2/pt not_active Application Discontinuation
- 2016-06-03 CA CA2988299A patent/CA2988299C/en active Active
- 2016-06-03 CN CN202210968572.3A patent/CN115925878A/zh active Pending
- 2016-06-03 KR KR1020187000354A patent/KR20180033499A/ko not_active Ceased
- 2016-06-03 WO PCT/US2016/035858 patent/WO2016197018A1/en not_active Ceased
- 2016-06-03 AU AU2016270428A patent/AU2016270428B2/en not_active Ceased
-
2017
- 2017-12-04 ZA ZA2017/08223A patent/ZA201708223B/en unknown
-
2020
- 2020-11-09 US US17/092,539 patent/US11912755B2/en active Active
-
2021
- 2021-02-05 AU AU2021200765A patent/AU2021200765B2/en not_active Ceased
- 2021-09-28 JP JP2021158128A patent/JP7404320B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013027391A5 (enExample) | ||
| JP2019525744A5 (enExample) | ||
| JP2023522972A5 (enExample) | ||
| JP2009540801A5 (enExample) | ||
| JP2018537087A5 (enExample) | ||
| KR20180027560A (ko) | Rsv에 대한 백신 | |
| WO2015005500A1 (en) | Virus like particle comprising pd-1 antigen or pd-1 ligand antigen | |
| JP2017506886A5 (enExample) | ||
| JP2024180560A5 (enExample) | ||
| RU2014126587A (ru) | Химерная частица hpv | |
| TW202130363A (zh) | 變異型ｒｓｖ ｆ蛋白質及其利用 | |
| JP2015509506A5 (enExample) | ||
| EP3464331A1 (en) | Stabilized pre-fusion rsv f proteins | |
| CN104844712B (zh) | 肺炎链球菌蛋白抗原及其制备方法和应用 | |
| JP2014519817A5 (enExample) | ||
| CN108727503A (zh) | VZV重组gE-鞭毛素融合蛋白及其制备方法和应用 | |
| CN118994328A (zh) | 呼吸道合胞病毒疫苗及其制备方法和应用 | |
| US9925259B2 (en) | Immunogenic polypeptide surface layer-expressing bifidobacterium | |
| JP2016521566A5 (enExample) | ||
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| Elkins et al. | Plant production and functional characterization of catfish interleukin-22 as a natural immune stimulant for aquaculture fish | |
| JP2020522249A5 (enExample) | ||
| CN103102418B (zh) | 粒细胞集落刺激因子(G-CSF)及其突变体(mG-CSF)与人血清白蛋白第三结构域(3DHSA)的融合蛋白及应用 | |
| CN101538318B (zh) | 一种信号肽及其编码基因与应用 | |
| CN103232545A (zh) | 一种重组猪干扰素α1-Fc融合蛋白及其编码基因和表达方法 |